The Global MIS Sacroiliac Joint Fusion Market was valued at nearly $330 million in 2024. This is expected to increase over the forecast period at a CAGR of 8.8%, reaching $595 million by 2031.
The full market report suite on the global market for minimally invasive sacroiliac (MIS SI) joint fusion includes market analysis complete with units sold, ASPs, and market value.
MARKET DATA INCLUDED
Unit Sales & Average Selling Prices (ASP)
Market Size & Growth Trends
Procedure Numbers
Forecasts to 2031
Historical Data (2021–2024)
Market Drivers & Limiters
Competitive Landscape & Shares
Mergers & Acquisitions
Company Profiles & Product Portfolios
Global Sacroiliac Joint Fusion Market Trends
Growing recognition of sacroiliac joint dysfunction as a significant source of lower back pain
MIS techniques are increasingly preferred due to:
Faster recovery times
Reduced blood loss
Lower complication rates
Rising demand driven by both surgeon preference and patient outcomes
Expected surge in innovation across implant design and procedural efficiency
Global Market Share Insights
1. SI-BONE – Market Leader
First company to enter the MIS SI joint fusion market
Flagship product: iFuse Implant System® (iFuse®)
Held ~50% market share across all regions
Market strength driven by early-mover advantage, brand reputation, and robust clinical support
2. Medtronic – Second-Largest Competitor
Product: ANCHOR FS™
Ranked second in North America, Western Europe, and Rest of World
Strategic presence in mature and emerging markets with well-integrated procedural solutions
3. Globus Medical / NuVasive – Third-Largest Competitor
Product: ZYFUSE®
Ranked fourth in North America, third in Western Europe and Rest of World
Competitive due to focus on surgical innovation and bundling with spinal systems
Research Scope Summary
Regions
North America (Canada, United States)
Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela)
Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom)
Central & Eastern Europe (Baltic States, Bulgaria, Kazakhstan, Poland, Romania, Croatia, Czech Republic, Russia, Greece, Turkey, Hungary, Ukraine)
Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates)
Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Vietnam)
Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year:
2024
Forecast Period: 2025–2031
Historical Data: 2021–2024
Quantitative Data
Procedure Numbers
Market Size
Market Shares
Market Forecasts
Market Growth Rates
Units Sold
Average Selling Prices
Qualitative Data
Market Growth Trends
Market Limiters
Competitive Analysis & SWOT for Top Competitors
Mergers & Acquisitions
Company Profiles
Product Portfolios
FDA Recalls
Disruptive Technologies
Disease Overviews
Data Sources
Primary Interviews with Industry Leaders
Government Physician Data
Regulatory Data
Hospital Private Data
Import & Export Data
iData Research Internal Database
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook